| Financial Year |
March 31 2023 |
| Monetary Funds |
452,371,382.16 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
629,500.00 |
| Accounts Receivable |
357,924,103.10 |
| Advances to Suppliers |
89,342,106.63 |
| Other Receivables |
46,392,936.28 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
670,466,272.99 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
54,380,208.27 |
| Other Current Assets |
73,549,368.84 |
| Total Current Assets |
2,221,107,140.31 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
4,311,706.52 |
| Investment Properties |
-- |
| Fixed Assetes |
946,149,699.75 |
| Under-construction Projects |
49,069,193.64 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
153,967,151.54 |
| R&D expenses |
6,423,243.96 |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
41,479,597.90 |
| Deferred Income Tax Assets |
158,490,561.41 |
| Other Non-Current Assets |
-- |
| Sub-Total of Non-Current Assets |
1,373,903,827.49 |
| Total Assets |
3,595,010,967.80 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
378,945,786.70 |
| Accounts Payable |
477,542,618.08 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
88,967,184.31 |
| Taxes Payable |
9,917,083.26 |
| Interest Payable |
-- |
| Dividend Payable |
-- |
| Other payables |
200,823,752.18 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
368,958,979.84 |
| Other Current Liabilities |
81,546,533.88 |
| Sub-Total of Current Liabilities |
1,735,469,794.53 |
| Long-term Loans |
-- |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
779,379,936.20 |
| Special Payable |
-- |
| Estimatied Liabilities |
105,932,600.00 |
| Deferred Income Tax Liabilities |
3,192,504.02 |
| Other Non-Current Liabilities |
-- |
| Sub-Total of Non-Current Liabilities |
920,466,240.33 |
| Total Liabilities |
2,655,936,034.86 |
| Paid-In Capital(Or Share Stock) |
2,064,746,603.00 |
| Capital Surplus |
5,530,083,578.44 |
| Surplus Reserve |
113,267,211.40 |
| LESS:Treasury Stock |
4,479,746.00 |
| Undistributed Profits |
-6,745,433,954.53 |
| Minority Stockholder's Interest |
-37,595,565.09 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
976,670,498.03 |
| Owner's Equity（Stockholder's Equity） |
939,074,932.94 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
3,595,010,967.80 |
